Redfield Robert 4
4 · Traws Pharma, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Redfield Robert
Chief Medical Officer
Transactions
- Award
Common Stock
2024-04-01+97,500→ 97,500 total
Footnotes (1)
- [F1]Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into common stock of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.), par value $0.01 per share, on a one-for-one basis.